SUBSCRIBE
SUBSCRIBE

Dicerna Pharmaceuticals

NEWS
Dicerna Pharmaceuticals was acquired by Novo Nordisk in December 2021.
Business
Moderna’s Vaccines Boss Leaves Company
Giuseppe Ciaramella, formerly chief scientific officer of Moderna Therapeutics’ Valera unit, has left for an unidentified stealth-mode biotech startup.
March 7, 2018
 · 
3 min read
 · 
Mark Terry
Business
Boehringer Focuses on RNA
Boehringer has made a big push into RNA this month.
November 27, 2017
 · 
1 min read
 · 
Karl Thiel
Dicerna Could Pocket $201M in NASH R&D Deal With B
Business
Dicerna Could Pocket $201M in NASH R&D Deal With Boehringer Ingelheim
Dicerna and Boehringer Ingelheim today announced a research collaboration and license agreement to discover and develop novel RNAi therapeutics for the treatment of chronic liver diseases.
November 2, 2017
 · 
4 min read
 · 
Alex Keown
Policy
Sparring Over Trade Secrets, Dicerna Brings New Antitrust Suit Against Alnylam
August 11, 2017
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Alnylam Slaps Dicerna With Trade Secret Lawsuit
June 11, 2015
 · 
4 min read
Job Trends
Booming Dicerna Takes a Larger Space in Cambridge and Plans to Hire
February 26, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Tekmira Announces $24.5M Licensing And Collaboration Agreement With Dicerna Pharmaceuticals
November 17, 2014
 · 
2 min read
Load More
IN THE PRESS
Genetown
Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 01, 2021
July 1, 2021
 · 
4 min read
Drug Development
Dicerna Initiates Patient Dosing in ESTRELLA Phase 2 Clinical Trial of Belcesiran for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
June 22, 2021
 · 
8 min read
Genetown
Dicerna Announces Dosing Completion in Nedosiran PHYOX™4 Clinical Trial for Treatment of Primary Hyperoxaluria Type 3
June 16, 2021
 · 
9 min read
Genetown
Dicerna to Participate in 42nd Annual Goldman Sachs Global Healthcare Conference
June 3, 2021
 · 
3 min read
Genetown
Dicerna Announces FDA Acceptance of Lilly’s Investigational New Drug (IND) Application for LY3819469
May 27, 2021
 · 
7 min read
Business
Dicerna Announces Boehringer Ingelheim’s Acceptance of Candidate for Development Under RNAi Research Collaboration and License Agreement
May 24, 2021
 · 
7 min read
Genetown
Dicerna to Participate in Upcoming Investor Conferences - May 12, 2021
May 12, 2021
 · 
3 min read
Business
Dicerna Announces First Quarter 2021 Financial Results and Provides a Business Update
May 6, 2021
 · 
13 min read
Business
Dicerna to Report First Quarter 2021 Financial Results on May 6, 2021
April 29, 2021
 · 
2 min read
Business
Dicerna Sells OXLUMO™ (lumasiran) Royalty Interest to Royalty Pharma for Up to $240 Million
April 8, 2021
 · 
12 min read
Load More